{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:21:51Z","timestamp":1791408111188,"version":"4.3.3"},"reference-count":186,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009377","name":"Education Department of Hunan Province","doi-asserted-by":"publisher","award":["19A419"],"award-info":[{"award-number":["19A419"]}],"id":[{"id":"10.13039\/100009377","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.jsbmb.2022.106199","type":"journal-article","created":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T13:43:24Z","timestamp":1664545404000},"page":"106199","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"special_numbering":"C","title":["Regulation of progesterone receptor expression in endometriosis, endometrial cancer, and breast cancer by estrogen, polymorphisms, transcription factors, epigenetic alterations, and ubiquitin-proteasome system"],"prefix":"10.1016","volume":"227","author":[{"given":"Huijie","family":"Pu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaosha","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DiXian","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zifen","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsbmb.2022.106199_bib1","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.3390\/ijms21072440","article-title":"Curcumin and endometriosis","volume":"21","author":"Vall\u00e9e","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jsbmb.2022.106199_bib2","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1016\/j.cell.2021.04.041","article-title":"Endometriosis: etiology, pathobiology, and therapeutic prospects","volume":"184","author":"Saunders","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.jsbmb.2022.106199_bib3","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA: Cancer J. Clin."},{"key":"10.1016\/j.jsbmb.2022.106199_bib4","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.cct.2014.06.014","article-title":"Improving treatment for obese women with early stage cancer of the uterus: rationale and design of the levonorgestrel intrauterine device \u00b1 Metformin \u00b1 weight loss in endometrial cancer (feMME) trial","volume":"39","author":"Hawkes","year":"2014","journal-title":"Contemp. Clin. Trials"},{"key":"10.1016\/j.jsbmb.2022.106199_bib5","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1001\/jamaoncol.2015.0494","article-title":"Breast Cancer After Use of Estrogen Plus Progestin and Estrogen Alone","volume":"1","author":"Chlebowski","year":"2015","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.jsbmb.2022.106199_bib6","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1210\/edrv-11-2-266","article-title":"Progestin regulation of cellular proliferation","volume":"11","author":"Clarke","year":"1990","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.jsbmb.2022.106199_bib7","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1515\/hmbci-2016-0038","article-title":"Progesterone in normal and pathological pregnancy","volume":"27","author":"Di Renzo","year":"2016","journal-title":"Horm. Mol. Biol. Clin. Investig."},{"key":"10.1016\/j.jsbmb.2022.106199_bib8","first-page":"533","article-title":"Mammary gland development","volume":"4","author":"Hinck","year":"2012","journal-title":"WIREs Dev. Biol."},{"key":"10.1016\/j.jsbmb.2022.106199_bib9","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0002-9378(15)33275-0","article-title":"Cytoplasmic progesterone and estradiol receptors in normal, hyperplastic, and carcinomatous endometria: therapeutic implications","volume":"141","author":"Ehrlich","year":"1981","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.jsbmb.2022.106199_bib10","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0303-7207(95)03674-V","article-title":"Differential gene regulation by estrogen and progesterone in the primate endometrium","volume":"115","author":"Ace","year":"1995","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.jsbmb.2022.106199_bib11","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1136\/bmj.298.6667.147","article-title":"Risk of endometrial cancer after treatment with oestrogens alone or in conjunction with progestogens: results of a prospective study","volume":"298","author":"Persson","year":"1989","journal-title":"BMJ"},{"key":"10.1016\/j.jsbmb.2022.106199_bib12","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nature14583","article-title":"Progesterone receptor modulates ER\u03b1 action in breast cancer","volume":"523","author":"Mohammed","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.jsbmb.2022.106199_bib13","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0092-8674(02)00641-4","article-title":"Combinatorial control of gene expression by nuclear receptors and coregulators","volume":"108","author":"McKenna","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.jsbmb.2022.106199_bib14","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S1097-2765(01)00304-5","article-title":"Progesterone receptor contains a proline-rich motif that directly interacts with SH3 domains and activates c-Src family tyrosine kinases","volume":"8","author":"Boonyaratanakornkit","year":"2001","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jsbmb.2022.106199_bib15","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jsbmb.2003.11.008","article-title":"Differential regulation of the human progesterone receptor gene through an estrogen response element half site and Sp1 sites","volume":"88","author":"Petz","year":"2004","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2022.106199_bib16","first-page":"465","article-title":"Combinatorial control of gene expression by nuclear receptors and coregulators","volume":"4","author":"Neil","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.jsbmb.2022.106199_bib17","first-page":"3868","article-title":"New T47D breast cancer cell lines for the independent study of progesterone B- and A-receptors: only antiprogestin-occupied B-receptors are switched to transcriptional agonists by cAMP","volume":"54","author":"Sartorius","year":"1994","journal-title":"Cancer Res."},{"key":"10.1016\/j.jsbmb.2022.106199_bib18","first-page":"1256","article-title":"Antagonist-occupied human progesterone B-receptors activate transcription without binding to progesterone response elements and are dominantly inhibited by A-receptors","volume":"7","author":"Tung","year":"1993","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.jsbmb.2022.106199_bib19","first-page":"1244","article-title":"Human progesterone receptor A form is a cell- and promoter-specific repressor of human progesterone receptor B function","volume":"7","author":"Vegeto","year":"1993","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.jsbmb.2022.106199_bib20","first-page":"8356","article-title":"The A and B isoforms of the human progesterone receptor operate through distinct signaling pathways within target cells","volume":"14","author":"Wen","year":"1994","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.jsbmb.2022.106199_bib21","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0960-0760(97)00044-7","article-title":"An N-terminally truncated third progesterone receptor protein, PR(C), forms heterodimers with PR(B) but interferes in PR(B)-DNA binding","volume":"62","author":"Wei","year":"1997","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2022.106199_bib22","first-page":"1379","article-title":"An amino-terminal truncated progesterone receptor isoform, PRc, enhances progestin-induced transcriptional activity","volume":"10","author":"Wei","year":"1996","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.jsbmb.2022.106199_bib23","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1023\/A:1005941117247","article-title":"Progesterone receptor variants found in breast cells repress transcription by wild-type receptors","volume":"48","author":"Richer","year":"1998","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.jsbmb.2022.106199_bib24","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1677\/joe.1.06242","article-title":"Regulated expression of putative membrane progestin receptor homologues in human endometrium and gestational tissues","volume":"187","author":"Fernandes","year":"2005","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.jsbmb.2022.106199_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2020\/2196024","article-title":"Expression of membrane progesterone receptors in eutopic and ectopic endometrium of women with endometriosis","volume":"2020","author":"V\u00e1zquez-Mart\u00ednez","year":"2020","journal-title":"BioMed. Res. Int."},{"key":"10.1016\/j.jsbmb.2022.106199_bib26","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jsbmb.2018.01.011","article-title":"Membrane progesterone receptors \u03b2 and \u03b3 have potential as prognostic biomarkers of endometrial cancer","volume":"178","author":"Sinreih","year":"2018","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2022.106199_bib27","doi-asserted-by":"crossref","first-page":"755","DOI":"10.3892\/ijmm.2017.3060","article-title":"Progesterone suppresses triple-negative breast cancer growth and metastasis to the brain via membrane progesterone receptor \u03b1","volume":"40","author":"Zhou","year":"2017","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.jsbmb.2022.106199_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.steroids.2022.109040","article-title":"The role of progesterone receptor membrane component (PGRMC) in the endometrium","volume":"184","author":"Vel\u00e1zquez Hern\u00e1ndez","year":"2022","journal-title":"Steroids"},{"key":"10.1016\/j.jsbmb.2022.106199_bib29","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.canlet.2014.09.036","article-title":"Progesterone receptor membrane component 1 deficiency attenuates growth while promoting chemosensitivity of human endometrial xenograft tumors","volume":"356","author":"Friel","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jsbmb.2022.106199_bib30","doi-asserted-by":"crossref","DOI":"10.1186\/s13058-020-01312-8","article-title":"Progesterone receptor membrane component 1 regulates lipid homeostasis and drives oncogenic signaling resulting in breast cancer progression","volume":"22","author":"Asperger","year":"2020","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.jsbmb.2022.106199_bib31","doi-asserted-by":"crossref","DOI":"10.1186\/s12964-021-00719-w","article-title":"Absence of progesterone receptor membrane component 1 reduces migration and metastasis of breast cancer","volume":"19","author":"Lee","year":"2021","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.jsbmb.2022.106199_bib32","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1210\/me.2006-0129","article-title":"Human homologs of the putative G protein-coupled membrane progestin receptors (mPRalpha, beta, and gamma) localize to the endoplasmic reticulum and are not activated by progesterone","volume":"20","author":"Krietsch","year":"2006","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.jsbmb.2022.106199_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2020.105599","article-title":"Systemic distribution of progesterone receptor subtypes in human tissues","volume":"199","author":"Asavasupreechar","year":"2020","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2022.106199_bib34","doi-asserted-by":"crossref","first-page":"9744","DOI":"10.1073\/pnas.1732707100","article-title":"Defective mammary gland morphogenesis in mice lacking the progesterone receptor B isoform","volume":"100","author":"Mulac-Jericevic","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.jsbmb.2022.106199_bib35","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1126\/science.289.5485.1751","article-title":"Subgroup of reproductive functions of progesterone mediated by progesterone receptor-B isoform","volume":"289","author":"Mulac-Jericevic","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.jsbmb.2022.106199_bib36","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0039-128X(03)00126-0","article-title":"Progesterone-dependent regulation of female reproductive activity by two distinct progesterone receptor isoforms","volume":"68","author":"Mulac-Jericevic","year":"2003","journal-title":"Steroids"},{"key":"10.1016\/j.jsbmb.2022.106199_bib37","unstructured":"Mousazadeh S.A.P.S.B. Imbalance Progesterone Receptor-A\/-B ratio via +331G\/A polymorphism enhance MMP-2, 9 expression in endometriosis. 2015."},{"key":"10.1016\/j.jsbmb.2022.106199_bib38","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1055\/s-2001-15111","article-title":"Regulation of estrogen receptor alpha and progesterone receptor (isoform A and B) expression in cultured human endometrial cells","volume":"109","author":"Prange-Kiel","year":"2001","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"10.1016\/j.jsbmb.2022.106199_bib39","first-page":"2897","article-title":"Progesterone receptor isoform A but not B is expressed in endometriosis","volume":"85","author":"Attia","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2022.106199_bib40","first-page":"836","article-title":"Regulation of human progesterone receptor isoforms A and B in uterine endometrial carcinoma by estrogen and insulin-like growth factor-1","volume":"82","author":"Zhang","year":"2002","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"10.1016\/j.jsbmb.2022.106199_bib41","first-page":"164","article-title":"Time-dependent and dose-dependent regulation of human progesterone receptor isoforms A and B in uterine endometrial carcinoma by human insulin-like growth factor-I","volume":"37","author":"Zhang","year":"2002","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"key":"10.1016\/j.jsbmb.2022.106199_bib42","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.cancergencyto.2007.02.002","article-title":"Down-regulation of the progesterone receptor by the methylation of progesterone receptor gene in endometrial cancer cells","volume":"175","author":"Ren","year":"2007","journal-title":"Cancer Genet. Cytogenet."},{"key":"10.1016\/j.jsbmb.2022.106199_bib43","doi-asserted-by":"crossref","first-page":"5209","DOI":"10.1074\/jbc.M110090200","article-title":"Differential gene regulation by the two progesterone receptor isoforms in human breast cancer cells","volume":"277","author":"Richer","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jsbmb.2022.106199_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0045993","article-title":"Differential regulation of breast cancer-associated genes by progesterone receptor isoforms PRA and PRB in a new bi-inducible breast cancer cell line","volume":"7","author":"Khan","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jsbmb.2022.106199_bib45","doi-asserted-by":"crossref","first-page":"18969","DOI":"10.1016\/S0021-9258(18)55158-9","article-title":"Direct transcriptional regulation of the progesterone receptor by retinoic acid diminishes progestin responsiveness in the breast cancer cell line T-47D","volume":"266","author":"Clarke","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jsbmb.2022.106199_bib46","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1210\/mend.13.10.0356","article-title":"Effect of overexpression of progesterone receptor A on endogenous progestin-sensitive endpoints in breast cancer cells","volume":"13","author":"McGowan","year":"1999","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.jsbmb.2022.106199_bib47","doi-asserted-by":"crossref","first-page":"4708","DOI":"10.1210\/endo.139.11.6317","article-title":"Stromal progesterone receptors mediate the inhibitory effects of progesterone on estrogen-induced uterine epithelial cell deoxyribonucleic acid synthesis","volume":"139","author":"Kurita","year":"1998","journal-title":"Endocrinology"},{"key":"10.1016\/j.jsbmb.2022.106199_bib48","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1096\/fj.11-193334","article-title":"Epithelial progesterone receptor exhibits pleiotropic roles in uterine development and function","volume":"26","author":"Franco","year":"2012","journal-title":"FASEB J."},{"key":"10.1016\/j.jsbmb.2022.106199_bib49","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1096\/fj.11-193334","article-title":"Epithelial progesterone receptor exhibits pleiotropic roles in uterine development and function","volume":"26","author":"Franco","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/j.jsbmb.2022.106199_bib50","doi-asserted-by":"crossref","first-page":"9744","DOI":"10.1073\/pnas.1732707100","article-title":"Defective mammary gland morphogenesis in mice lacking the progesterone receptor B isoform","volume":"100","author":"Mulac-Jericevic","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.jsbmb.2022.106199_bib51","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1126\/science.289.5485.1751","article-title":"Subgroup of reproductive functions of progesterone mediated by progesterone receptor-B isoform","volume":"289","author":"Mulac-Jericevic","year":"2000","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.jsbmb.2022.106199_bib52","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/humrep\/15.suppl_3.48","article-title":"Heterogeneity of progesterone receptors A and B expression in human endometrial glands and stroma","volume":"15","author":"Mote","year":"2000","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.jsbmb.2022.106199_bib53","first-page":"2963","article-title":"Colocalization of progesterone receptors A and B by dual immunofluorescent histochemistry in human endometrium during the menstrual cycle","volume":"84","author":"Mote","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2022.106199_bib54","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S1877-1173(09)87002-6","article-title":"Progesterone receptor action in leiomyoma and endometrial cancer","volume":"87","author":"Kim","year":"2009","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"10.1016\/j.jsbmb.2022.106199_bib55","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12967-019-1814-6","article-title":"Comprehensive bioinformatics analysis of acquired progesterone resistance in endometrial cancer cell line","volume":"17","author":"Li","year":"2019","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.jsbmb.2022.106199_bib56","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1111\/j.1349-7006.2006.00332.x","article-title":"Progesterone receptor isoforms as a prognostic marker in human endometrial carcinoma","volume":"97","author":"Saito","year":"2006","journal-title":"Cancer Sci."},{"key":"10.1016\/j.jsbmb.2022.106199_bib57","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.ygyno.2008.10.032","article-title":"Expression of estrogen receptor-alpha and -beta and progesterone receptor-A and -B in a large cohort of patients with endometrioid endometrial cancer","volume":"112","author":"Jongen","year":"2009","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.jsbmb.2022.106199_bib58","first-page":"4576","article-title":"Relative expression of progesterone receptors A and B in endometrioid cancers of the endometrium","volume":"61","author":"Arnett-Mansfield","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.jsbmb.2022.106199_bib59","first-page":"S1","article-title":"Endometrial cancer: incidence, prognostic factors, diagnosis, and treatment","volume":"24","author":"Creasman","year":"1997","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.jsbmb.2022.106199_bib60","first-page":"881","article-title":"Progesterone inhibits human endometrial cancer cell growth and invasiveness: down-regulation of cellular adhesion molecules through progesterone B receptors","volume":"62","author":"Dai","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.jsbmb.2022.106199_bib61","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/j.1349-7006.1996.tb00255.x","article-title":"Effects of sex steroids and growth factors on migration and invasion of endometrial adenocarcinoma SNG-M cells in vitro","volume":"87","author":"Ueda","year":"1996","journal-title":"Jpn J. Cancer Res."},{"key":"10.1016\/j.jsbmb.2022.106199_bib62","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s12672-011-0065-7","article-title":"Progesterone receptor-B induction of BIRC3 protects endometrial cancer cells from AP1-59-mediated apoptosis","volume":"2","author":"Neubauer","year":"2011","journal-title":"Horm. Cancer"},{"key":"10.1016\/j.jsbmb.2022.106199_bib63","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1210\/en.2007-0756","article-title":"The regulation and function of the forkhead transcription factor, Forkhead box O1, is dependent on the progesterone receptor in endometrial carcinoma","volume":"149","author":"Ward","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.jsbmb.2022.106199_bib64","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0090-8258(03)00089-1","article-title":"Progestin suppresses matrix metalloproteinase production in endometrial cancer","volume":"89","author":"Di Nezza","year":"2003","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.jsbmb.2022.106199_bib65","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1677\/JME-06-0030","article-title":"Histone deacetylase inhibition and progesterone act synergistically to stimulate baboon glycodelin gene expression","volume":"38","author":"Jaffe","year":"2007","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.jsbmb.2022.106199_bib66","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1093\/molehr\/4.9.899","article-title":"Involvement of cyclin-dependent kinase inhibitor p27Kip1 in growth inhibition of endometrium in the secretory phase and of hyperplastic endometrium treated with progesterone","volume":"4","author":"Shiozawa","year":"1998","journal-title":"Mol. Hum. Reprod."},{"key":"10.1016\/j.jsbmb.2022.106199_bib67","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1080\/17446651.2017.1314783","article-title":"The role of progesterone and the progesterone receptor in cancer","volume":"12","author":"Check","year":"2017","journal-title":"Expert Rev. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2022.106199_bib68","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1046\/j.1365-2265.2003.01766.x","article-title":"The correlation between the response to progestogen treatment and the expression of progesterone receptor B and 17beta-hydroxysteroid dehydrogenase type 2 in human endometrial carcinoma","volume":"58","author":"Utsunomiya","year":"2003","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.jsbmb.2022.106199_bib69","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1757-2215-5-31","article-title":"Dienogest increases the progesterone receptor isoform B\/A ratio in patients with ovarian endometriosis","volume":"5","author":"Hayashi","year":"2012","journal-title":"J. Ovarian Res."},{"key":"10.1016\/j.jsbmb.2022.106199_bib70","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.bpobgyn.2004.02.001","article-title":"Immunology of endometriosis","volume":"18","author":"Paul","year":"2004","journal-title":"Best Pract. Res Clin. Obstet. Gynaecol."},{"key":"10.1016\/j.jsbmb.2022.106199_bib71","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1210\/endo.143.6.8885","article-title":"Global gene profiling in human endometrium during the window of implantation","volume":"143","author":"Kao","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.jsbmb.2022.106199_bib72","doi-asserted-by":"crossref","first-page":"4809","DOI":"10.1210\/endo.140.10.7070","article-title":"Progesterone receptor regulates decidual prolactin expression in differentiating human endometrial stromal cells","volume":"140","author":"Brosens","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.jsbmb.2022.106199_bib73","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.mce.2005.11.041","article-title":"Progesterone resistance in endometriosis: link to failure to metabolize estradiol","volume":"248","author":"Bulun","year":"2006","journal-title":"Mol. Cell Endocrinol."},{"key":"10.1016\/j.jsbmb.2022.106199_bib74","doi-asserted-by":"crossref","first-page":"4459","DOI":"10.1210\/jc.2007-0725","article-title":"Progesterone receptor regulates Bcl-2 gene expression through direct binding to its promoter region in uterine leiomyoma cells","volume":"92","author":"Yin","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2022.106199_bib75","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1423-0127-21-2","article-title":"Endometrial progesterone resistance and PCOS","volume":"21","author":"Li","year":"2014","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.jsbmb.2022.106199_bib76","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/aogs.13156","article-title":"Progesterone resistance in endometriosis: origins, consequences and interventions","volume":"96","author":"Patel","year":"2017","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"10.1016\/j.jsbmb.2022.106199_bib77","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1080\/09513590.2018.1490404","article-title":"Reviewing the role of progesterone therapy in endometriosis","volume":"35","author":"Abdul Karim","year":"2019","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.jsbmb.2022.106199_bib78","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1093\/oxfordjournals.humrep.a135901","article-title":"Immunohistochemical characterization of proliferation, oestrogen receptor and progesterone receptor expression in endometriosis: comparison of eutopic and ectopic endometrium with normal cycling endometrium","volume":"10","author":"Jones","year":"1995","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.jsbmb.2022.106199_bib79","first-page":"1","article-title":"Classen-Linke. Altered expression of progesterone receptor isoforms A and B in human eutopic endometrium in endometriosis patients","author":"MMWO","year":"2013","journal-title":"Ann. Anat."},{"key":"10.1016\/j.jsbmb.2022.106199_bib80","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/B978-0-12-416673-8.00012-5","article-title":"The hyperplastic phenotype in PR-A and PR-B transgenic mice: lessons on the role of estrogen and progesterone receptors in the mouse mammary gland and breast cancer","volume":"93","author":"Sampayo","year":"2013","journal-title":"Vitam. Horm."},{"key":"10.1016\/j.jsbmb.2022.106199_bib81","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.1073\/pnas.97.7.3044","article-title":"Impact of progesterone receptor on cell-fate decisions during mammary gland development","volume":"97","author":"Shyamala","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.jsbmb.2022.106199_bib82","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nature09027","article-title":"Control of mammary stem cell function by steroid hormone signalling","volume":"465","author":"Asselin-Labat","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.jsbmb.2022.106199_bib83","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/nature09091","article-title":"Progesterone induces adult mammary stem cell expansion","volume":"465","author":"Joshi","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.jsbmb.2022.106199_bib84","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1210\/me.2006-0304","article-title":"Progestin effects on breast cancer cell proliferation, proteases activation, andin vivo development of metastatic phenotype all depend on progesterone receptor capacity to activate cytoplasmic signaling pathways","volume":"21","author":"Carnevale","year":"2007","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.jsbmb.2022.106199_bib85","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1210\/er.2010-0016","article-title":"Cracking the estrogen receptor's posttranslational code in breast tumors","volume":"32","author":"Le Romancer","year":"2011","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.jsbmb.2022.106199_bib86","doi-asserted-by":"crossref","DOI":"10.1023\/A:1014820500738","article-title":"Loss of co-ordinate expression of progesterone receptors A and B is\u00a0is an early event in breast carcinogenesis","author":"Mote","year":"2002","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.jsbmb.2022.106199_bib87","doi-asserted-by":"crossref","first-page":"412","DOI":"10.5306\/wjco.v5.i3.412","article-title":"Biological subtypes of breast cancer: prognostic and therapeutic implications","volume":"5","author":"Yersal","year":"2014","journal-title":"World J. Clin. Oncol."},{"key":"10.1016\/j.jsbmb.2022.106199_bib88","first-page":"82","article-title":"Predictive markers in breast cancer\u2014the present","author":"S J L","year":"2008","journal-title":"Histopathology"},{"key":"10.1016\/j.jsbmb.2022.106199_bib89","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jsbmb.2009.01.005","article-title":"Comparing the effects of atamestane, toremifene and tamoxifen alone and in combination, on bone, serum lipids and uterus in ovariectomized rats","volume":"113","author":"Goss","year":"2009","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2022.106199_bib90","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.3892\/ol.2015.2962","article-title":"Molecular mechanisms of tamoxifen-associated endometrial cancer","volume":"9","author":"Hu","year":"2015","journal-title":"Oncol. Lett."},{"issue":"3","key":"10.1016\/j.jsbmb.2022.106199_bib91","first-page":"25","article-title":"Selective oestrogen receptor modulators","volume":"53","author":"Burger","year":"2000","journal-title":"Horm. Res"},{"issue":"14","key":"10.1016\/j.jsbmb.2022.106199_bib92","first-page":"155","article-title":"The influence of tamoxifen on plasma coagulation and serous fibrinolysis","author":"Jankowski","year":"1993","journal-title":"Eur. J. Gynaecol. Oncol."},{"key":"10.1016\/j.jsbmb.2022.106199_bib93","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1615\/CritRevOncog.v13.i4.20","article-title":"Role of the progesterone receptor (PR) and the PR isoforms in breast cancer","volume":"13","author":"Mc Cormack","year":"2007","journal-title":"Crit. Rev. Oncog."},{"key":"10.1016\/j.jsbmb.2022.106199_bib94","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.matbio.2016.05.003","article-title":"Estrogen receptor beta modulates breast cancer cells functional properties, signaling and expression of matrix molecules","volume":"56","author":"Piperigkou","year":"2016","journal-title":"Matrix Biol."},{"key":"10.1016\/j.jsbmb.2022.106199_bib95","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1073\/pnas.1323719111","article-title":"Differential expression of estrogen receptor \u03b1, \u03b21, and \u03b22 in lobular and ductal breast cancer","volume":"111","author":"Huang","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.jsbmb.2022.106199_bib96","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41416-020-01094-y","article-title":"Insulin receptor substrate-1 (IRS-1) mediates progesterone receptor-driven stemness and endocrine resistance in oestrogen receptor+ breast cancer","volume":"124","author":"Dwyer","year":"2021","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jsbmb.2022.106199_bib97","doi-asserted-by":"crossref","first-page":"10542","DOI":"10.1128\/MCB.24.24.10542-10557.2004","article-title":"Phosphorylation of progesterone receptor serine 400 mediates ligand-independent transcriptional activity in response to activation of cyclin-dependent protein kinase 2","volume":"24","author":"Pierson-Mullany","year":"2004","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.jsbmb.2022.106199_bib98","doi-asserted-by":"crossref","first-page":"6366","DOI":"10.1016\/S0021-9258(19)43455-8","article-title":"Mechanisms regulating the concentration and the conformation of progesterone receptor(s) in the uterus","volume":"248","author":"Edwin Milgrom","year":"1973","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jsbmb.2022.106199_bib99","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3109\/10799898109038795","article-title":"The regulation of progesterone receptor by 17 beta estradiol and tamoxifen in the Zr-75-1 human breast cancer cell line in defined medium","volume":"2","author":"Allegra","year":"1981","journal-title":"J. Recept Res."},{"key":"10.1016\/j.jsbmb.2022.106199_bib100","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1210\/endo-121-5-1642","article-title":"Progesterone receptor regulation by 17 beta-estradiol in human endometrial carcinoma grown in nude mice","volume":"121","author":"Clarke","year":"1987","journal-title":"Endocrinology"},{"key":"10.1016\/j.jsbmb.2022.106199_bib101","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jsbmb.2003.11.004","article-title":"Molecular mechanism of estrogen receptor (ER)\u03b1-specific, estradiol-dependent expression of the progesterone receptor (PR) B-isoform","volume":"88","author":"Fl\u00f6totto","year":"2004","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2022.106199_bib102","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1002\/j.1460-2075.1990.tb08280.x","article-title":"Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B","volume":"9","author":"Kastner","year":"1990","journal-title":"EMBO J."},{"key":"10.1016\/j.jsbmb.2022.106199_bib103","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1210\/mend.14.7.0493","article-title":"Sp1 binding sites and an estrogen response element half-site are involved in regulation of the human progesterone receptor A promoter","volume":"14","author":"Petz","year":"2000","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.jsbmb.2022.106199_bib104","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0303-7207(02)00415-X","article-title":"Estrogen receptor \u03b1 and Sp1 regulate progesterone receptor gene expression","volume":"201","author":"Schultz","year":"2003","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.jsbmb.2022.106199_bib105","doi-asserted-by":"crossref","first-page":"4583","DOI":"10.1210\/en.2002-220369","article-title":"Estrogen receptor \u03b1 and activating protein-1 mediate estrogen responsiveness of the progesterone receptor gene in MCF-7 breast cancer cells","volume":"143","author":"Petz","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.jsbmb.2022.106199_bib106","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1210\/me.2003-0105","article-title":"Fos and jun inhibit estrogen-induced transcription of the human progesterone receptor gene through an activator protein-1 site","volume":"18","author":"Petz","year":"2004","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.jsbmb.2022.106199_bib107","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1128\/MCB.01398-09","article-title":"Cyclin D1 enhances the response to estrogen and progesterone by regulating progesterone receptor expression","volume":"30","author":"Yang","year":"2010","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.jsbmb.2022.106199_bib108","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/bjc.1995.92","article-title":"A germline TaqI restriction fragment length polymorphism in the progesterone receptor gene in ovarian carcinoma","volume":"71","author":"McKenna","year":"1995","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jsbmb.2022.106199_bib109","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1677\/jme.1.02170","article-title":"The PROGINS polymorphism of the human progesterone receptor diminishes the response to progesterone","volume":"38","author":"Romano","year":"2007","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.jsbmb.2022.106199_bib110","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1007\/s00404-014-3308-3","article-title":"Association of the progesterone receptor gene polymorphism (PROGINS) with endometriosis: a meta-analysis","volume":"290","author":"Pabalan","year":"2014","journal-title":"Arch. Gynecol. Obstet."},{"key":"10.1016\/j.jsbmb.2022.106199_bib111","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/carcin\/bgq263","article-title":"Progesterone receptor gene variants and risk of endometrial cancer","volume":"32","author":"O'Mara","year":"2011","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.jsbmb.2022.106199_bib112","doi-asserted-by":"crossref","first-page":"760","DOI":"10.2174\/1871530319666191125153050","article-title":"Molecular evaluation of PROGINS mutation in progesterone receptor gene and determination of its frequency, distribution pattern and association with breast cancer susceptibility in Saudi Arabia","volume":"20","author":"Albalawi","year":"2020","journal-title":"Endocr. Metab. Immune Disord. Drug Targets"},{"key":"10.1016\/j.jsbmb.2022.106199_bib113","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.steroids.2008.02.005","article-title":"Progesterone receptor (PROGINS) polymorphism and the risk of ovarian cancer","volume":"73","author":"Leite","year":"2008","journal-title":"Steroids"},{"key":"10.1016\/j.jsbmb.2022.106199_bib114","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00404-014-3344-z","article-title":"Association of the +331G\/A progesterone receptor gene (PgR) polymorphism with risk of endometrial cancer in Caucasian women: a meta-analysis","volume":"291","author":"Pabalan","year":"2015","journal-title":"Arch. Gynecol. Obstet."},{"key":"10.1016\/j.jsbmb.2022.106199_bib115","first-page":"185","article-title":"Differential expression of progesterone receptor isoforms related to PGR +331g\/a polymorphism in endometriosis: a case-control study","volume":"17","author":"Mousazadeh","year":"2019","journal-title":"Int. J. Reprod. Biomed."},{"key":"10.1016\/j.jsbmb.2022.106199_bib116","doi-asserted-by":"crossref","first-page":"12263","DOI":"10.1073\/pnas.192172299","article-title":"A functional polymorphism in the promoter of the progesterone receptor gene associated with endometrial cancer risk","volume":"99","author":"De Vivo","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.jsbmb.2022.106199_bib117","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1158\/0008-5472.CAN-05-2715","article-title":"GATA5 activation of the progesterone receptor gene promoter in breast cancer cells is influenced by the +331G\/A polymorphism","volume":"66","author":"Huggins","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.jsbmb.2022.106199_bib118","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s10549-007-9627-3","article-title":"Progesterone receptor polymorphisms and risk of breast cancer: results from two Australian breast cancer studies","volume":"109","author":"Johnatty","year":"2008","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.jsbmb.2022.106199_bib119","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/nrg3207","article-title":"Transcription factors: from enhancer binding to developmental control","volume":"13","author":"Spitz","year":"2012","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.jsbmb.2022.106199_bib120","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1210\/en.2011-1766","article-title":"The loss of Hoxa5 function causes estrous acyclicity and ovarian epithelial inclusion cysts","volume":"153","author":"Gendronneau","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.jsbmb.2022.106199_bib121","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3390\/jdb4020013","article-title":"Hoxa5: a key player in development and disease","volume":"4","author":"Jeannotte","year":"2016","journal-title":"J. Dev. Biol."},{"key":"10.1016\/j.jsbmb.2022.106199_bib122","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1038\/35016125","article-title":"Compromised HOXA5 function can limit p53 expression in human breast tumours","volume":"405","author":"Venu Raman","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.jsbmb.2022.106199_bib123","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1074\/jbc.M411018200","article-title":"HOXA5-twist interaction alters p53 homeostasis in breast cancer cells","volume":"280","author":"Stasinopoulos","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jsbmb.2022.106199_bib124","doi-asserted-by":"crossref","first-page":"26551","DOI":"10.1074\/jbc.C000324200","article-title":"HOXA5 regulates expression of the progesterone receptor","volume":"275","author":"Raman","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jsbmb.2022.106199_bib125","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1101\/gad.12.12.1907","article-title":"The C\/EBPbeta transcription factor regulates epithelial cell proliferation and differentiation in the mammary gland","volume":"12","author":"Robinson","year":"1998","journal-title":"Genes Dev."},{"key":"10.1016\/j.jsbmb.2022.106199_bib126","article-title":"Expression of the CCAAT\/enhancer-binding proteins C\/EBP \u03b1, C\/EBP \u03b2 and C\/EBP \u03b4 in breast cancer: correlations with clinicopathologic parameters and cell-cycle regulatory proteins","author":"Karin Milde-Langosch","year":"2003","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.jsbmb.2022.106199_bib127","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.mce.2018.06.001","article-title":"C\/EBP\u03b2 LIP and c-Jun synergize to regulate expression of the murine progesterone receptor","volume":"477","author":"Wang","year":"2018","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.jsbmb.2022.106199_bib128","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1093\/jnci\/89.24.1887","article-title":"Overexpression of C_EBPbeta-LIP, a naturally occurring, dominant-negative transcription factor, in human breast cancer","volume":"89","author":"Cynthia","year":"1997","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.jsbmb.2022.106199_bib129","first-page":"359","article-title":"C\/EBPbeta (CCAAT\/enhancer binding protein) controls cell fate determination during mammary gland development","volume":"14","author":"Seagroves","year":"2000","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.jsbmb.2022.106199_bib130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1003863","article-title":"Activin-like kinase 2 functions in peri-implantation uterine signaling in mice and humans","volume":"9","author":"Clementi","year":"2013","journal-title":"PLoS Genet."},{"key":"10.1016\/j.jsbmb.2022.106199_bib131","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1101\/gad.1463306","article-title":"RNPC1, an RNA-binding protein and a target of the p53 family, is required for maintaining the stability of the basal and stress-induced p21 transcript","volume":"20","author":"Shu","year":"2006","journal-title":"Genes Dev."},{"key":"10.1016\/j.jsbmb.2022.106199_bib132","doi-asserted-by":"crossref","first-page":"23680","DOI":"10.1074\/jbc.M113.480186","article-title":"RNPC1, an RNA-binding protein and a p53 target, regulates macrophage inhibitory cytokine-1 (MIC-1) expression through mRNA stability","volume":"288","author":"Yin","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jsbmb.2022.106199_bib133","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1128\/MCB.00215-12","article-title":"p73 expression is regulated by RNPC1, a target of the p53 family, via mRNA stability","volume":"32","author":"Yan","year":"2012","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.jsbmb.2022.106199_bib134","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1101\/gad.2069311","article-title":"Translational repression of p53 by RNPC1, a p53 target overexpressed in lymphomas","volume":"25","author":"Zhang","year":"2011","journal-title":"Genes Dev."},{"key":"10.1016\/j.jsbmb.2022.106199_bib135","doi-asserted-by":"crossref","first-page":"9614","DOI":"10.1073\/pnas.0912594107","article-title":"RNPC1, an RNA-binding protein and a target of the p53 family, regulates p63 expression through mRNA stability","volume":"107","author":"Zhang","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.jsbmb.2022.106199_bib136","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1186\/1471-2407-14-322","article-title":"RNA-binding protein RNPC1: acting as a tumor suppressor in breast cancer","volume":"14","author":"Xue","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jsbmb.2022.106199_bib137","doi-asserted-by":"crossref","first-page":"16387","DOI":"10.18632\/oncotarget.12016","article-title":"RNPC1 enhances progesterone receptor functions by regulating its mRNA stability in breast cancer","volume":"8","author":"Lou","year":"2017","journal-title":"Oncotarget"},{"issue":"33","key":"10.1016\/j.jsbmb.2022.106199_bib138","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/ng1089","article-title":"Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals","author":"Jaenisch","year":"2003","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jsbmb.2022.106199_bib139","doi-asserted-by":"crossref","first-page":"804","DOI":"10.4161\/epi.6.7.16262","article-title":"Epigenetic mechanisms and cancer: an interface between the environment and the genome","volume":"6","author":"Herceg","year":"2011","journal-title":"Epigenetics"},{"key":"10.1016\/j.jsbmb.2022.106199_bib140","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/nrg3074","article-title":"Non-coding RNAs in human disease","volume":"12","author":"Esteller","year":"2011","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.jsbmb.2022.106199_bib141","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.2174\/13816128113199990532","article-title":"Epigenetic modification restores functional PR expression in endometrial cancer cells","volume":"20","author":"Yang","year":"2014","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jsbmb.2022.106199_bib142","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/GRF.0000000000000298","article-title":"A review of the epigenetic contributions to endometriosis","volume":"60","author":"Grimstad","year":"2017","journal-title":"Clin. Obstet. Gynecol."},{"key":"10.1016\/j.jsbmb.2022.106199_bib143","doi-asserted-by":"crossref","first-page":"847","DOI":"10.2217\/epi.15.10","article-title":"Role of epigenetic modifications in luminal breast cancer","volume":"7","author":"Abdel-Hafiz","year":"2015","journal-title":"Epigenomics"},{"key":"10.1016\/j.jsbmb.2022.106199_bib144","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/npp.2012.112","article-title":"DNA methylation and its basic function","volume":"38","author":"Moore","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jsbmb.2022.106199_bib145","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/B978-0-12-380866-0.60002-2","article-title":"DNA methylation and cancer","volume":"70","author":"Kulis","year":"2010","journal-title":"Adv. Genet."},{"key":"10.1016\/j.jsbmb.2022.106199_bib146","first-page":"805","article-title":"Methylation of estrogen and progesterone receptor gene 5\u2032 CpG islands correlates with lack of estrogen and progesterone receptor gene expression in breast tumors","volume":"2","author":"Lapidus","year":"1996","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.jsbmb.2022.106199_bib147","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ygyno.2007.06.019","article-title":"Epigenetic considerations for endometrial cancer prevention, diagnosis and treatment","volume":"107","author":"Clare Zhou","year":"2007","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.jsbmb.2022.106199_bib148","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1007\/s43032-020-00226-2","article-title":"Epigenetics of estrogen and progesterone receptors in endometriosis","volume":"27","author":"Chen","year":"2020","journal-title":"Reprod. Sci."},{"key":"10.1016\/j.jsbmb.2022.106199_bib149","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1073\/pnas.1520441113","article-title":"Aberrant activation of canonical Notch1 signaling in the mouse uterus decreases progesterone receptor by hypermethylation and leads to infertility","volume":"113","author":"Su","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.jsbmb.2022.106199_bib150","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.1158\/1078-0432.CCR-10-2950","article-title":"Progesterone receptor isoform-specific promoter methylation: association of PRA promoter methylation with worse outcome in breast cancer patients","volume":"17","author":"Pathiraja","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jsbmb.2022.106199_bib151","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nature05458","article-title":"Histone arginine methylation regulates pluripotency in the early mouse embryo","volume":"445","author":"Torres-Padilla","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.jsbmb.2022.106199_bib152","first-page":"319","article-title":"Role of histone phosphorylation in chromatin dynamics and its implications in diseases","volume":"41","author":"Oki","year":"2007","journal-title":"Subcell. Biochem"},{"key":"10.1016\/j.jsbmb.2022.106199_bib153","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/nrm1761","article-title":"The diverse functions of histone lysine methylation","volume":"6","author":"Martin","year":"2005","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jsbmb.2022.106199_bib154","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1111\/j.1742-4658.2011.08058.x","article-title":"The histone demethylase JARID1A regulates progesterone receptor expression","volume":"278","author":"Stratmann","year":"2011","journal-title":"FEBS J."},{"key":"10.1016\/j.jsbmb.2022.106199_bib155","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.jsbmb.2022.106199_bib156","doi-asserted-by":"crossref","first-page":"7065","DOI":"10.1158\/0008-5472.CAN-05-1783","article-title":"MicroRNA Gene Expression Deregulation in Human Breast Cancer","volume":"65","author":"Iorio","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.jsbmb.2022.106199_bib157","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1095\/biolreprod.109.081059","article-title":"Genomic profiling of microRNAs and messenger RNAs reveals hormonal regulation in microRNA expression in human endometrium","volume":"82","author":"Kuokkanen","year":"2010","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.jsbmb.2022.106199_bib158","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.12688\/f1000research.12005.1","article-title":"MicroRNAs in the development and neoplasia of the mammary gland","volume":"6","author":"Jena","year":"2017","journal-title":"F1000Res"},{"key":"10.1016\/j.jsbmb.2022.106199_bib159","doi-asserted-by":"crossref","first-page":"7529","DOI":"10.1073\/pnas.1200650109","article-title":"MicroRNA-200a serves a key role in the decline of progesterone receptor function leading to term and preterm labor","volume":"109","author":"Williams","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jsbmb.2022.106199_bib160","doi-asserted-by":"crossref","first-page":"R27","DOI":"10.1186\/bcr2257","article-title":"MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2\/neu receptor status in breast cancer","volume":"11","author":"Lowery","year":"2009","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.jsbmb.2022.106199_bib161","doi-asserted-by":"crossref","first-page":"25963","DOI":"10.18632\/oncotarget.15657","article-title":"MicroRNA regulation of progesterone receptor in breast cancer","volume":"8","author":"Gilam","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jsbmb.2022.106199_bib162","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1093\/carcin\/bgx126","article-title":"MiRNA-513a-5p inhibits progesterone receptor expression and constitutes a risk factor for breast cancer: the ORDET prospective study","volume":"39","author":"Muti","year":"2018","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.jsbmb.2022.106199_bib163","doi-asserted-by":"crossref","first-page":"8332","DOI":"10.1158\/0008-5472.CAN-09-2206","article-title":"Widespread estrogen-dependent repression of micrornas involved in breast tumor cell growth","volume":"69","author":"Maillot","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.jsbmb.2022.106199_bib164","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1080\/15384047.2017.1373216","article-title":"miR-129-2 mediates down-regulation of progesterone receptor in response to progesterone in breast cancer cells","volume":"18","author":"Godbole","year":"2017","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.jsbmb.2022.106199_bib165","doi-asserted-by":"crossref","first-page":"E1316","DOI":"10.1210\/jc.2012-1018","article-title":"Endometrial miR-181a and miR-98 expression is altered during transition from normal into cancerous state and TargetPGR, PGRMC1, CYP19A1, DDX3X, and TIMP3","volume":"97","author":"Panda","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2022.106199_bib166","doi-asserted-by":"crossref","first-page":"13899","DOI":"10.1074\/jbc.M111.301275","article-title":"Combined analysis of microRNome and 3\u2032-UTRome reveals a species-specific regulation of progesterone receptor expression in the endometrium of rhesus monkey","volume":"287","author":"Liu","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jsbmb.2022.106199_bib167","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1210\/en.2018-00374","article-title":"miR-194-3p represses the progesterone receptor and decidualization in eutopic endometrium from women with endometriosis","volume":"159","author":"Tianjiao Pei","year":"2018","journal-title":"Endocrine Soc."},{"key":"10.1016\/j.jsbmb.2022.106199_bib168","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1093\/humrep\/dew223","article-title":"miR-196a overexpression activates the MEK\/ERK signal and represses the progesterone receptor and decidualization in eutopic endometrium from women with endometriosis","volume":"31","author":"Zhou","year":"2016","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.jsbmb.2022.106199_bib169","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/BF02705243","article-title":"The ubiquitin-proteasome system","volume":"31","author":"Nandi","year":"2006","journal-title":"J. Biosci."},{"key":"10.1016\/j.jsbmb.2022.106199_bib170","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ejphar.2018.03.022","article-title":"mechanism of cardiovascular toxicity to protesome inhibitors","volume":"828","author":"Mara Gavazzoni","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jsbmb.2022.106199_bib171","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1073\/pnas.97.3.1032","article-title":"Phosphorylation of human progesterone receptors at serine-294 by mitogen-activated protein kinase signals their degradation by the 26S proteasome","volume":"97","author":"Lange","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.jsbmb.2022.106199_bib172","doi-asserted-by":"crossref","first-page":"86011","DOI":"10.18632\/oncotarget.13322","article-title":"Fibroblast growth factor signalling induces loss of progesterone receptor in breast cancer cells","volume":"7","author":"Piasecka","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jsbmb.2022.106199_bib173","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0960-0760(03)00221-8","article-title":"MAP kinases couple multiple functions of human progesterone receptors: degradation, transcriptional synergy, and nuclear association","volume":"85","author":"Qiu","year":"2003","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2022.106199_bib174","doi-asserted-by":"crossref","first-page":"6122","DOI":"10.1128\/MCB.21.18.6122-6131.2001","article-title":"Transcriptional hyperactivity of human progesterone receptors is coupled to their ligand-dependent down-regulation by mitogen-activated protein kinase-dependent phosphorylation of serine 294","volume":"21","author":"Shen","year":"2001","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.jsbmb.2022.106199_bib175","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1210\/me.2011-1042","article-title":"p38 and p42\/44 MAPKs differentially regulate progesterone receptor A and B isoform stabilization","volume":"25","author":"Khan","year":"2011","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.jsbmb.2022.106199_bib176","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1038\/sj.emboj.7601602","article-title":"CUE domain containing 2 regulates degradation of progesterone receptor by ubiquitin-proteasome","volume":"26","author":"Zhao","year":"2007","journal-title":"EMBO J."},{"key":"10.1016\/j.jsbmb.2022.106199_bib177","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1038\/emboj.2013.173","article-title":"The emerging family of CULLIN3-RING ubiquitin ligases (CRL3s): cellular functions and disease implications","volume":"32","author":"Genschik","year":"2013","journal-title":"EMBO J."},{"key":"10.1016\/j.jsbmb.2022.106199_bib178","doi-asserted-by":"crossref","first-page":"14537","DOI":"10.1074\/jbc.C000881200","article-title":"The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by a breast cancer-derived mutation","volume":"276","author":"Hashizume","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jsbmb.2022.106199_bib179","first-page":"3210","article-title":"Tumor suppressor SPOP mediates the proteasomal degradation of progesterone receptors (PRs) in breast cancer cells","volume":"5","author":"Gao","year":"2015","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.jsbmb.2022.106199_bib180","doi-asserted-by":"crossref","first-page":"3422","DOI":"10.1158\/0008-5472.CAN-10-3670","article-title":"BRCA1 counteracts progesterone action by ubiquitination leading to progesterone receptor degradation and epigenetic silencing of target promoters","volume":"71","author":"Veronica","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.jsbmb.2022.106199_bib181","doi-asserted-by":"crossref","first-page":"12694","DOI":"10.1016\/S0021-9258(19)38400-5","article-title":"Progesterone receptor regulation by retinoic acid in the human breast cancer cell line T-47D","volume":"265","author":"Clarke","year":"1990","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jsbmb.2022.106199_bib182","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.3349\/ymj.2016.57.6.1468","article-title":"Decreased progesterone receptor B\/A ratio in endometrial cells by tumor necrosis factor-alpha and peritoneal fluid from patients with endometriosis","volume":"57","author":"Chae","year":"2016","journal-title":"Yonsei Med. J."},{"key":"10.1016\/j.jsbmb.2022.106199_bib183","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1095\/biolreprod.114.119255","article-title":"Influence of AKT on progesterone action in endometrial diseases","volume":"91","author":"Lee","year":"2014","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.jsbmb.2022.106199_bib184","doi-asserted-by":"crossref","first-page":"E1871","DOI":"10.1210\/jc.2013-1661","article-title":"Increased AKT or MEK1\/2 activity influences progesterone receptor levels and localization in endometriosis","volume":"98","author":"Eaton","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2022.106199_bib185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10549-015-3665-z","article-title":"Breast cancer risk and clinical implications for germline PTEN mutation carriers","volume":"165","author":"Ngeow","year":"2017","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.jsbmb.2022.106199_bib186","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1210\/me.2002-0318","volume":"17","author":"Cui","year":"2003","journal-title":"Mol. Endocrinol."}],"container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076022001509?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076022001509?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T00:10:59Z","timestamp":1760746259000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960076022001509"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":186,"alternative-id":["S0960076022001509"],"URL":"https:\/\/doi.org\/10.1016\/j.jsbmb.2022.106199","relation":{},"ISSN":["0960-0760"],"issn-type":[{"value":"0960-0760","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regulation of progesterone receptor expression in endometriosis, endometrial cancer, and breast cancer by estrogen, polymorphisms, transcription factors, epigenetic alterations, and ubiquitin-proteasome system","name":"articletitle","label":"Article Title"},{"value":"The Journal of Steroid Biochemistry and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsbmb.2022.106199","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106199"}}